Taken together, our results found that LWE treatment increases the SCFA-producing genus and other anti-obesity gut microbiota, which together may exert a beneficial effect on the prevention of MetS and obesity in Lepr−/− rats. This evidence concerns the gene LEPR and metabolic syndrome.